Jundishapur Journal of Microbiology

Published by: Kowsar

Dissemination of Extended-Spectrum β-Lactamases and Quinolone Resistance Genes Among Clinical Isolates of Uropathogenic Escherichia coli in Children

Iraj Sedighi 1 , Mohammad Reza Arabestani 2 , 3 , Ali Rahimbakhsh 4 , Zahra Karimitabar 2 and Mohammad Yousef Alikhani 2 , 3 , *
Authors Information
1 Department of Pediatric, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, IR Iran
2 Department of Microbiology, Faculty of Medicine, Hamadan University of Medical Sciences, Hamadan, IR Iran
3 Brucellosis Research Center, Hamadan University of Medical Sciences, Hamadan, IR Iran
4 Department of Microbiology, Faculty of Basic and Medical Sciences, Islamic Azad University of Zanjan, Zanjan, IR Iran
Article information
  • Jundishapur Journal of Microbiology: July 01, 2015, 8 (7); e19184
  • Published Online: July 25, 2015
  • Article Type: Research Article
  • Received: March 30, 2014
  • Revised: July 23, 2014
  • Accepted: July 26, 2014
  • DOI: 10.5812/jjm.19184v2

To Cite: Sedighi I, Arabestani M R, Rahimbakhsh A, Karimitabar Z, Alikhani M Y. et al. Dissemination of Extended-Spectrum β-Lactamases and Quinolone Resistance Genes Among Clinical Isolates of Uropathogenic Escherichia coli in Children, Jundishapur J Microbiol. 2015 ;8(7):e19184. doi: 10.5812/jjm.19184v2.

Abstract
Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Murray PR, Baron EJ, Jorgensen J. H. , Landry ML, Michael A, Pfaller MA. Manual of Clinical Microbiology. 2007;
  • 2. Piatti G, Mannini A, Balistreri M, Schito AM. Virulence factors in urinary Escherichia coli strains: phylogenetic background and quinolone and fluoroquinolone resistance. J Clin Microbiol. 2008; 46(2): 480-7[DOI][PubMed]
  • 3. White B. Diagnosis and treatment of urinary tract infections in children. Am Fam Physician. 2011; 83(4): 409-15[PubMed]
  • 4. Wang M, Tran JH, Jacoby GA, Zhang Y, Wang F, Hooper DC. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother. 2003; 47(7): 2242-8[PubMed]
  • 5. Wang M, Sahm DF, Jacoby GA, Hooper DC. Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrob Agents Chemother. 2004; 48(4): 1295-9[PubMed]
  • 6. Jeong JY, Yoon HJ, Kim ES, Lee Y, Choi SH, Kim NJ, et al. Detection of qnr in clinical isolates of Escherichia coli from Korea. Antimicrob Agents Chemother. 2005; 49(6): 2522-4
  • 7. Schleiss MR. Nelson text book of pediatrics. 2011; [DOI]
  • 8. Martinez-Martinez L, Pascual A, Jacoby GA. Quinolone resistance from a transferable plasmid. Lancet. 1998; 351(9105): 797-9[DOI][PubMed]
  • 9. Robicsek A, Jacoby GA, Hooper DC. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis. 2006; 6(10): 629-40[DOI][PubMed]
  • 10. Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev. 2009; 22(4): 664-89[DOI][PubMed]
  • 11. Khodursky AB, Zechiedrich EL, Cozzarelli NR. Topoisomerase IV is a target of quinolones in Escherichia coli. Proc Natl Acad Sci U S A. 1995; 92(25): 11801-5[PubMed]
  • 12. Tran JH, Jacoby GA, Hooper DC. Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase. Antimicrob Agents Chemother. 2005; 49(1): 118-25[DOI][PubMed]
  • 13. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966; 45(4): 493-6[PubMed]
  • 14. Performance standards for antimicrobial susceptibility testing: seventeenth informational supplement. 2007;
  • 15. Kim HB, Park CH, Kim CJ, Kim EC, Jacoby GA, Hooper DC. Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob Agents Chemother. 2009; 53(2): 639-45[DOI][PubMed]
  • 16. Chroma M, Kolar M. Genetic methods for detection of antibiotic resistance: focus on extended-spectrum beta-lactamases. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010; 154(4): 289-96[PubMed]
  • 17. Cattoir V, Poirel L, Rotimi V, Soussy CJ, Nordmann P. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother. 2007; 60(2): 394-7[DOI][PubMed]
  • 18. Datta P, Thakur A, Mishra B, Gupta V. Prevalence of clinical strains resistant to various beta-lactams in a tertiary care hospital in India. Jpn J Infect Dis. 2004; 57(4): 146-9[PubMed]
  • 19. Daoud Z, Hakime N. [Prevalence and susceptibility patterns of extended-spectrum betalactamase-producing Escherichia coli and Klebsiella pneumoniae in a general university hospital in Beirut, Lebanon]. Rev Esp Quimioter. 2003; 16(2): 233-8[PubMed]
  • 20. Shayanfar N, Rezaei M, Ahmadi M, Ehsanipour F. Evaluation of extended spectrum beta-lactamase (ESBL) positive strains of Klebsiella pneumoniae and Escherichia coli in bacterial cultures. Iran J Pathol. 2010; 5: 34-9
  • 21. Franiczek R, Dolna I, Krzyzanowska B, Szufnarowski K, Kowalska-Krochmal B. Conjugative transfer of multiresistance plasmids from ESBL-positive Escherichia coli and Klebsiella spp. clinical isolates to Escherichia coli strain K12 C600. Adv Clin Exp Med. 2007; 16(2): 239-47
  • 22. Bali E, Acik, L. , Sultan, N. . Phenotypic and molecular characterization of SHV, TEM and CTX-M and extended spectrum beta -lactamase produced by Escherichia coli, Acinobacter baumannii and Klebsiella isolates in a Turkish hospital. Afr J Microbiol Res. 2010; 4(8): 650-4
  • 23. Sorlozano A, Gutierrez J, Fernandez F, Soto MJ, Piedrola G. A preliminary study on the presence of extended-spectrum beta-lactamases (ESBL) in clinical isolates of Escherichia coli in Granada (Spain). Ann Microbiol. 2004; 54(2): 99-104
  • 24. Park Y, Kang HK, Bae IK, Kim J, Kim JS, Uh Y, et al. Prevalence of the extended-spectrum beta-lactamase and qnr genes in clinical isolates of Escherichia coli. Korean J Lab Med. 2009; 29(3): 218-23[DOI][PubMed]
  • 25. Hussain M, Hasan F, Shah AA, Hameed A, Jung M, Rayamajhi N, et al. Prevalence of class A and AmpC beta-lactamases in clinical Escherichia coli isolates from Pakistan Institute of Medical Science, Islamabad, Pakistan. Jpn J Infect Dis. 2011; 64(3): 249-52[PubMed]
  • 26. Yazdi M, Nazemi A, Miri Nargesi MS, Khatami Nejad MR. Prevallence of SHV/CTX-M/TEM beta lactamase resistance genes in Escherichia coli isolated from UTI in Tehran city. Iran J Pathol. 2010; 4: 48-54
  • 27. Rodriguez-Villalobos H, Malaviolle V, Frankard J, de Mendonca R, Nonhoff C, Struelens MJ. In vitro activity of temocillin against extended spectrum beta-lactamase-producing Escherichia coli. J Antimicrob Chemother. 2006; 57(4): 771-4[DOI][PubMed]
  • 28. Bonnedahl J, Drobni M, Gauthier-Clerc M, Hernandez J, Granholm S, Kayser Y, et al. Dissemination of Escherichia coli with CTX-M type ESBL between humans and yellow-legged gulls in the south of France. PLoS One. 2009; 4(6)[DOI][PubMed]
  • 29. Padmini B, Appalaraju SB. Extended spectrum beta lactamases in urinary isolates of Escherichia coli and Klebsiella pneumonia - prevalence and susceptibility pattern in a tertiary care hospital. Ind J Med Microbiol. 2004; 22(3): 172-4
  • 30. Oktem IM, Gulay Z, Bicmen M, Gur D, Hitit Project Study Group. . qnrA prevalence in extended-spectrum beta-lactamase-positive Enterobacteriaceae isolates from Turkey. Jpn J Infect Dis. 2008; 61(1): 13-7[PubMed]
  • 31. Bouchakour M, Zerouali K, Gros Claude JD, Amarouch H, El Mdaghri N, Courvalin P, et al. Plasmid-mediated quinolone resistance in expanded spectrum beta lactamase producing enterobacteriaceae in Morocco. J Infect Dev Ctries. 2010; 4(12): 779-803[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments